David S. Siegel, M.D., Ph.D
Board Certifications: Internal Medicine and Medical Oncology
Languages: English
Locations: Hackensack, NJ
Call Hackensack, NJ: (551) 996-5900
David S. Siegel, MD, PhD, is a board-certified oncologist who works with the Regional Cancer Care Associates (RCCA) network. He treats patients in Hackensack, NJ, for a wide variety of cancer types and hematology conditions, with a special focus on myeloma. His treatment approach emphasizes compassion and a personalized approach while using the most advanced developments in cancer care. Contact RCCA today for a consultation with Dr. Siegel.
Like many members of the RCCA team, Dr. Siegel has broad expertise. He is capable of treating a full range of solid tumors and malignant blood disorders, helping patients combat nearly any diagnosis. His special area of interest, however, is in myelomas. He has unique expertise in handling the following conditions:
Multiple myeloma
Smoldering or asymptomatic myeloma
Waldenstrom’s Macroglobulinemia
AL (light chain) amyloidosis
In cancer and myeloma care, Dr. Siegel acts as a care coordinator and advisor. He carefully evaluates each patient’s condition and needs to develop a personalized treatment plan. Through the RCCA network, his patients gain access to well-established and breakthrough therapies, including chemotherapy, hormone therapy, targeted therapy, and immunotherapy. Dr. Siegel’s office is also equipped to provide stem cell transplants and Car-T gene therapy.
Academic Appointments and Achievements
Dr. Siegel has treated patients in his New Jersey community for over 14 years. Throughout his academic and medical career, he has earned numerous awards for his dedication to research. Dr. Siegel’s accolades and achievements include:
- Martin Scholarship for Academic Excellence
- American Society of Clinical Oncology Young Investigator Award
Dr. Siegel is also an active member of multiple regional, national, and international medical organizations. His memberships include:
- American Medical Association (AMA)
- American College of Physicians (ACP)
- American Association for Cancer Research
- American Society of Bone Marrow Transplantation
- American Society of Hematology (ASH)
- American Society of Clinical Oncology (ASCO)
- Southwest Oncology Group
- Arkansas Medical Association
For an oncologist who is active in cancer research, these memberships are an invaluable resource. They connect Dr. Siegel with hundreds or thousands of other oncologists and researchers nationwide. Through them, he has access to the latest journals, research findings, and guidelines, in addition to collaboration opportunities. These memberships empower Dr. Siegel to provide a higher level of care for his patients and help them feel confident in his services.
Education
- Medical school: New York School of Medicine
- Residency: New York University Bellevue Medical Center, Internal Medicine
- Fellowship: Memorial Sloan Kettering Cancer Center, Hematology and Oncology
- Board certifications: Internal Medicine and Medical Oncology
About David S. Siegel, MD, PhD
Dr. David Siegel has been active in myeloma research throughout his medical career. The research opportunities were what drew him to the field. “It was a field in which I thought I could contribute,” he explains, “both clinically and scientifically.”
More importantly, however, he was drawn to the opportunity to build relationships. Cancer and myeloma treatments are long-term processes that take place at an extremely vulnerable time in the patient’s life. Patients often grow close with their oncologists, creating deep bonds with doctors who care for them on an emotional level, not just a medical one. In Dr. Siegel’s words, “it is an opportunity to establish meaningful personal relationships with people who need my help.”
Dr. Siegel emphasizes this relationship whenever he meets with a new patient. “I will take care of them as I would my brother or sister,” he says, “with love and respect.”
He also adds that relationship opportunities are available elsewhere, as well. “If given the chance,” he says, “patients can and often do become part of a social network to bring them together with other patients sharing the same burdens.” Patients become part of the family at RCCA, and they can also find connections with community resources and support groups. These connections can be invaluable when it comes to navigating the emotional struggles of cancer treatment.
Another important part of respectful care, according to Dr. Siegel, is understanding his own limitations. In his words, “I could not sit across the desk from someone to offer them care if I thought they could receive better care somewhere else.” Dr. Siegel wants patients to receive the best care available and will provide appropriate referrals if he believes another office will help them more effectively.
All offices, including Dr. Siegel’s, are becoming better at providing effective treatment. Dr. Siegel states that he is lucky to be part of many important breakthroughs in myeloma care. The field is moving quickly, and Dr. Siegel is confident that it will continue to progress with even newer and better treatment for patients with cancer and myeloma.
Locations
Dr. Siegel treats patients at RCCA’s Hackensack, NJ, location.
Hospital Affiliations
He also maintains an affiliation with the Hackensack University Medical Center.
We are here for you
For more information or to schedule an appointment, call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.